Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline and Counseling for Smoking Cessation in Cancer Patients
NCT06218823Phase 4Completed
- Sponsor
- University of Wisconsin–Madison
- Start
- Mar 2024
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of varenicline in nicotine dependence, sponsored by University of Wisconsin–Madison. Started Mar 2024; status: completed.
02
Drugs
varenicline
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT06218823.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06218823.